Because STAT3 over-expression is closely related to CML drug resistance and has been implicated in a poor prognosis [17, 41], we evaluated the role of STATIP1 in IM resistance. This evidence concerns the gene STAT3 and chronic myelogenous leukemia, BCR-ABL1 positive.